Harvard Bioscience, Inc. HBIO
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +32.84%
- 1 year
- +41.27%
- Open
- 8.80
- Prev close
- 8.80
- Mkt cap
- 40.52M
- Vol
- 23.17K
- Avg vol
- 19.26K
- EPS
- -2.31
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.80
- High
- 8.92
- Forward P/E
- 14.00
- Beta
- 1.31
- Short ratio
- 2.66
- Inst. own
- 75.99%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.30
- 200-d avg
- 3.04
- 1y target
- 6.25
2Y chart
Events in this range
- Nov 7, 2024Earnings: -0.02; estimate 0.05; surprise -140%
- Mar 16, 2026Split: 1 for 10
Signals (86)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 2 days ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| RSI: Overbought | Oct 5, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| RSI: Overbought | Sep 10, 2026 | 1 month ago |
| RSI: Overbought | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 2 months ago |
| SMA: Bullish | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 17, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jul 2, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | May 29, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| SMA: Bullish | May 26, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | May 12, 2026 | 5 months ago |
| MACD: Buy Signal | May 5, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 15, 2026 | 6 months ago |
| SMA: Bullish | Apr 15, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 15, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 10, 2026 | 6 months ago |
| SMA: Bearish | Apr 9, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 20, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 20, 2026 | 7 months ago |
| SMA: Bullish | Mar 19, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 6, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 10, 2026 | 8 months ago |
| SMA: Bullish | Feb 9, 2026 | 8 months ago |
| RSI: Oversold | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Jan 30, 2026 | 9 months ago |
| RSI: Oversold | Jan 30, 2026 | 9 months ago |
| SMA: Bearish | Jan 8, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 9, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 20, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| SMA: Bearish | Nov 5, 2025 | 12 months ago |
| SMA: Bullish | Nov 4, 2025 | 12 months ago |
| RSI: Overbought | Oct 30, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 28, 2025 | 1 year ago |
| RSI: Oversold | Oct 17, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 6, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 2, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 25, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Sep 3, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 2, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 26, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 20, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 19, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 15, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 7, 2025 | 1 year ago |
| SMA: Bullish | Aug 5, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| SMA: Bullish | Jul 17, 2025 | 1 year ago |
| SMA: Bearish | Jul 15, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 25, 2025 | 1 year ago |
| SMA: Bullish | Jun 3, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 29, 2025 | 1 year ago |
| RSI: Overbought | May 29, 2025 | 1 year ago |
| RSI: Oversold | Apr 29, 2025 | 1 year ago |
| RSI: Oversold | Apr 10, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 7, 2025 | 1 year ago |
| RSI: Oversold | Feb 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
Key statistics
- Market cap
- 91.59M
- Enterprise value
- 133.38M
- Trailing P/E
- 0.00
- Forward P/E
- 14.00
- PEG ratio
- 0.00
- Price / sales
- 0.94
- Price / book
- 1.40
- EPS (TTM)
- -0.33
- Beta
- 1.31
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -14.57%
- Revenue (TTM)
- 97.73M
- Revenue growth
- -13.40%
- Free cash flow
- 6.06M
- Total cash
- 4.57M
- Total debt
- 45.91M
- Return on equity
- -20.40%
- Shares outstanding
- 43.62M
- Short % of float
- 1.11%
- 50-day average
- 2.30
- 200-day average
- 3.04
Analyst view
Consensus: none
- Target (low)
- 5.50
- Target (mean)
- 6.25
- Target (high)
- 7.00
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.05.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.05 | -0.02 | -0.07 | -140.00% |
| Aug 8, 2024 | Jun 1, 2024 | 0.05 | -0.03 | -0.08 | -160.00% |
| Aug 8, 2024 | Jun 1, 2024 | 0.05 | 0.00 | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.02 | 0.02 | 0.00 | 0.00% |
| May 7, 2024 | Mar 1, 2024 | 0.02 | 0.00 | — | — |
| Mar 7, 2024 | Dec 1, 2023 | 0.05 | 0.01 | -0.04 | -80.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 22, 2023 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Apr 26, 2023 | Benchmark | main | — | Buy |
| Apr 26, 2023 | Keybanc | main | — | Overweight |
| Mar 10, 2023 | Benchmark | reit | — | Buy |
| Nov 9, 2022 | Keybanc | main | — | Overweight |
| Aug 5, 2022 | Keybanc | main | — | Overweight |
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- harvardbioscience.com
News
Your note
Sign in to keep a note on HBIO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COTE JENNIFER | Chief Financial Officer | Stock Award(Grant) | Mar 4, 2024 | 168,738 |
| EADE KATHERINE ANNE | Director | Stock Award(Grant) | May 20, 2024 | 311,126 |
| EDRICK ALAN IAN | Director | Stock Award(Grant) | May 20, 2024 | 273,911 |
| GREEN JAMES W | Chief Executive Officer | Purchase | Jun 12, 2024 | 3,111,090 |
| LOEWALD THOMAS W | Director | Stock Award(Grant) | May 20, 2024 | 295,311 |
| LOY BERTRAND | Director | Stock Award(Grant) | May 20, 2024 | 556,208 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 6.69% | 2,916,176 | 6.12M | Sep 29, 2024 |
| Punch & Associates Investment Management, Inc. | 6.36% | 2,772,700 | 5.82M | Sep 29, 2024 |
| Harvey Partners, LLC | 6.22% | 2,715,000 | 5.70M | Sep 29, 2024 |
| AMH Equity Ltd. | 5.48% | 2,388,868 | 5.02M | Sep 29, 2024 |
| Vanguard Group Inc | 4.94% | 2,154,052 | 4.52M | Sep 29, 2024 |
| Granahan Investment Management LLC | 4.28% | 1,865,429 | 3.92M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.89% | 1,261,693 | 2.65M | Sep 29, 2024 |
| Heartland Value Fund | 2.75% | 1,200,000 | 2.52M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.18% | 952,121 | 2.00M | Oct 30, 2024 |
| Royce Micro-Cap Fund | 1.48% | 647,017 | 1.36M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.33% | 579,986 | 1.22M | Sep 29, 2024 |
| JNL Series Trust-JNL/Multi Manager Small Cap GrowthFd | 1.04% | 453,803 | 952.99K | Sep 29, 2024 |